A carregar...
SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope
Therapeutic options that directly enhance cardiomyocyte contractility in chronic heart failure (HF) therapy are currently limited and do not improve prognosis. In fact, most positive inotropic agents, such as β-adrenoreceptor agonists and PDE inhibitors, which have been assessed in HF patients, caus...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3874695/ https://ncbi.nlm.nih.gov/pubmed/24138023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12472 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|